Table 3 Prevalence and severity of orthostatic symptoms according to muscle mass status in patients with Parkinson’s disease
LMM (n = 141) | NMM (n = 264) | P value | |
|---|---|---|---|
Orthostatic symptom prevalence, % | 74 (52.5%) | 117 (44.3%) | 0.082 |
SCOPA-AUT item 14 positivity, % | 64 (45.4%) | 102 (38.6%) | 0.273 |
SCOPA-AUT item 15 positivity, % | 43 (30.5%) | 56 (21.2%) | 0.080 |
SCOPA-AUT item 16 positivity, % | 1 (0.7%) | 1 (0.4%) | 0.508 |
Orthostatic symptom severity | 1.16 (1.60) | 0.82 (1.25) | 0.070 |
SCOPA-AUT item 14 score | 0.70 (0.93) | 0.53 (0.80) | 0.206 |
SCOPA-AUT item 15 score | 0.46 (0.82) | 0.28 (0.62) | 0.045 |
SCOPA-AUT item 16 score | 0.01 (0.08) | 0.00 (0.06) | 0.575 |